Skip to content

Author

V. Mishra

We have 4 of 63 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery

Viruses are no longer used merely as naturally occurring tools for gene transfer or as blunt cytolytic agents. Researchers are rewriting their genomes, capsids, tropisms, regulatory elements, and payloads to create therapeutic systems that sense disease, execute conditional programs, and remodel pathological tissue. In...

Rawan H. Alsharedeh, A. Aljabali, M. Obeid et al. · 0 citations
Review Oct 2026

Harnessing Artificial Intelligence-driven Approaches in the Diagnosis and Management of Diabetes and Diabetes-Associated Complications.

Diabetes mellitus is a global health issue with escalating metabolic dysfunction, clinical heterogeneity, and rising microvascular and macrovascular consequences. Traditional diabetes diagnosis, risk assessment, treatment selection, and complication surveillance rely on periodic clinical measures and population-level r...

Yachana Mishra, R. Kanday, Simran Kauts et al. · 0 citations
Review Open access Oct 2026

CAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges

Simple Summary Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary immunotherapy that engineers a patient’s own immune T cells to specifically target and destroy malignant cells in hematological malignancies. This approach has transformed the treatment of relapsed acute lymphoblastic leukemia, lymphomas,...

Alaa A. A. Aljabali, Mohammad A. Obeid, A. Alqudah et al. · 0 citations
Review Open access Jul 2026

Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease

This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.

Yachana Misha, Radheshyam Jena, Aman Shukla et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.